Stay updated with breaking news from Abivax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Michael Ferguson has a strong track record in the biopharmaceutical industry, having held senior positions for commercialization and marketing of drugs in the field of Gastroenterology and specifically
18.04.2023 - EQS-News: ABIVAX / Key word(s): Personnel Abivax appoints Michael Ferguson as Chief Commerical Officer 18.04.2023 / 18:00 CET/CEST The issuer is solely responsible for the content of this announcement. Abivax appoints Michael Ferguson as Chief ... Seite 1
The analysis demonstrates clinical remission in 52.5% (n=114) of 217 moderate to severe ulcerative colitis (UC) patients (intent-to-treat population, ITT) after two years (96 weeks) of once-daily oral
Marc's appointment bolsters Abivax's position as a leader in the field of chronic inflammatory bowel diseasesCorinna zur Bonsen-Thomas steps down as acting Chair and remains a Board MemberProf. Hartmut
PARIS, FRANCE / ACCESSWIRE / March 16, 2023 / Abivax SA (Euronext Paris:FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune